These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 14695413)

  • 1. Pulmonary alveolar proteinosis.
    Trapnell BC; Whitsett JA; Nakata K
    N Engl J Med; 2003 Dec; 349(26):2527-39. PubMed ID: 14695413
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary alveolar proteinosis--is host defense awry?
    Doerschuk CM
    N Engl J Med; 2007 Feb; 356(6):547-9. PubMed ID: 17287475
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary alveolar proteinosis.
    Presneill JJ; Nakata K; Inoue Y; Seymour JF
    Clin Chest Med; 2004 Sep; 25(3):593-613, viii. PubMed ID: 15331195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Adult Primary Alveolar Proteinosis.
    Rodríguez Portal JA
    Arch Bronconeumol; 2015 Jul; 51(7):344-9. PubMed ID: 25896950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
    Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
    N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy options in pulmonary alveolar proteinosis.
    Luisetti M; Kadija Z; Mariani F; Rodi G; Campo I; Trapnell BC
    Ther Adv Respir Dis; 2010 Aug; 4(4):239-48. PubMed ID: 20647242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.
    Cooke KR; Nishinakamura R; Martin TR; Kobzik L; Brewer J; Whitsett JA; Bungard D; Murray R; Ferrara JL
    Bone Marrow Transplant; 1997 Oct; 20(8):657-62. PubMed ID: 9383229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF.
    Price A; Manson D; Cutz E; Dell S
    Pediatr Pulmonol; 2006 Apr; 41(4):367-70. PubMed ID: 16475176
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of GM-CSF as a cause of pulmonary alveolar proteinosis.
    Hallman M; Merritt TA
    J Clin Invest; 1996 Feb; 97(3):589-90. PubMed ID: 8609211
    [No Abstract]   [Full Text] [Related]  

  • 14. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Seymour JF
    Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of surfactant protein production in a mouse model of secondary pulmonary alveolar proteinosis.
    Shibasaki M; Hashimoto K; Okamoto M; Hayashi Y; Imaizumi K; Hashimoto N; Ozaki N; Yokoi T; Takagi K; Hasegawa Y; Shimokata K; Kawabe T
    Am J Respir Cell Mol Biol; 2009 May; 40(5):536-42. PubMed ID: 18931325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis].
    Tredano M; Blic JD; Griese M; Fournet JC; Elion J; Bahuau M
    Ann Biol Clin (Paris); 2001; 59(2):131-48. PubMed ID: 11282516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
    Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
    Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
    Nakata K; Kanazawa H; Watanabe M
    Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.